These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4427237)

  • 21. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
    Pinkerton TC; Perry JA; Rateike JD
    J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition and oxidative metabolism of phenylbutazone in man.
    Aarbakke J; Bakke OM; Milde EJ; Davies DS
    Eur J Clin Pharmacol; 1977; 11(5):359-66. PubMed ID: 880975
    [No Abstract]   [Full Text] [Related]  

  • 25. GLC determination of plasma concentrations of gamma-oxo metabolite of phenylbutazone.
    Midha KK; McGilveray IJ; Cooper JK
    J Pharm Sci; 1978 Feb; 67(2):279-81. PubMed ID: 621659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P; Higgins AJ; Mawhinney IC; Reid DS
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
    Caturla MC; Cusido E
    J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
    Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
    Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Kinetics of anti-inflammatory drugs in serum and synovia of horses (author's transl)].
    Lehmann W; Wintzer HJ; Frey HH
    Dtsch Tierarztl Wochenschr; 1981 Jun; 88(6):218-20. PubMed ID: 7026207
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of desipramine on intestinal absorption of phenylbutazone and other drugs.
    Consolo S; Garattini S
    Eur J Pharmacol; 1969; 6(3):322-6. PubMed ID: 5799193
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans.
    Yasuda Y; Shindo T; Mitani N; Ishida N; Oono F; Kageyama T
    J Pharm Sci; 1982 May; 71(5):565-72. PubMed ID: 7097505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reduction of plasma concentrations of phenylbutazone and oxyphenbutazone in smokers].
    Ollagnier M; Queneau P; Latour JF; Brazier JL; Decousus H; Faucon G
    Therapie; 1982; 37(5):549-56. PubMed ID: 7179323
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GLC determination of phenylbutazone in human plasma.
    Sioufi A; Caudal F; Marfil F
    J Pharm Sci; 1978 Feb; 67(2):243-5. PubMed ID: 621647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of therapeutic agents in blood.
    Marks V; Lindup WE; Baylis EM
    Adv Clin Chem; 1973; 16():47-109. PubMed ID: 4589494
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolism of phenylbutazone in the rat.
    Bakke OM; Draffan GH; Davies DS
    Xenobiotica; 1974 Apr; 4(4):237-54. PubMed ID: 4603132
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of phenylbutazone in neonatal foals.
    Wilcke JR; Crisman MV; Sams RA; Gerken DF
    Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.